These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1913553)

  • 1. Prognostic indicators of metastatic bone disease in human breast cancer.
    Kamby C; Rasmussen BB; Kristensen B
    Cancer; 1991 Nov; 68(9):2045-50. PubMed ID: 1913553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.
    Jacobson AF; Shapiro CL; Van den Abbeele AD; Kaplan WD
    Cancer; 2001 Jan; 91(1):17-24. PubMed ID: 11148555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer.
    Kamby C; Dirksen H; Vejborg I; Daugaard S; Guldhammer B; Rossing N; Mouridsen HT
    Cancer; 1987 Apr; 59(8):1524-9. PubMed ID: 3545442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival After Palliative Radiotherapy in Patients with Breast Cancer and Bone-only Metastases.
    Nieder C; Dalhaug A; Pawinski A; Mannsåker B; Haukland E
    In Vivo; 2016 11-12; 30(6):879-883. PubMed ID: 27815475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and radiologic characteristics of bone metastases in breast cancer.
    Kamby C; Vejborg I; Daugaard S; Guldhammer B; Dirksen H; Rossing N; Mouridsen HT
    Cancer; 1987 Nov; 60(10):2524-31. PubMed ID: 3664434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osseous metastases of breast cancer. Clinical, biochemical, radiographic, and scintigraphic evaluation of response to therapy.
    Hortobagyi GN; Libshitz HI; Seabold JE
    Cancer; 1984 Feb; 53(3):577-82. PubMed ID: 6692261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
    Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
    J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer.
    Kamby C; Guldhammer B; Vejborg I; Rossing N; Dirksen H; Daugaard S; Mouridsen HT
    Cancer; 1987 Sep; 60(6):1306-12. PubMed ID: 3621113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic and prognostic value of serum bone Gla protein (osteocalcin) in patients with recurrent breast cancer.
    Kamby C; Egsmose C; Söletormos G; Dombernowsky P
    Scand J Clin Lab Invest; 1993 Aug; 53(5):439-46. PubMed ID: 8210965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow micrometastases in esophageal carcinoma: a 10-year follow-up study.
    Gray RT; O'Donnell ME; Verghis RM; McCluggage WG; Maxwell P; McGuigan JA; Spence GM
    Dis Esophagus; 2012; 25(8):709-15. PubMed ID: 22243663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunocytochemical detection of tumor cells in bone marrow as a prognostic factor in breast carcinoma].
    Merkle E; Bähr J; Henke A; Bühner M; Martus P
    Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):662-9. PubMed ID: 7531659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of exclusive skeletal metastases in stage IV primary carcinoma of the breast.
    Chiedozi LC
    Surg Gynecol Obstet; 1988 Oct; 167(4):303-6. PubMed ID: 3420504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.
    Mansi JL; Berger U; Easton D; McDonnell T; Redding WH; Gazet JC; McKinna A; Powles TJ; Coombes RC
    Br Med J (Clin Res Ed); 1987 Oct; 295(6606):1093-6. PubMed ID: 3120893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
    Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
    BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prognostic significance of tumor cell detection in bone marrow of patients with breast cancer].
    Diel IJ; Kaufmann M; Costa SD; Kaul S; Krempien B; Goerner R; Bastert G
    Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):923-8. PubMed ID: 1707840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of proliferation markers Ki67, cyclin A, geminin and aurora-kinase A in primary breast carcinomas and corresponding distant metastases.
    Tökés AM; Szász AM; Geszti F; Lukács LV; Kenessey I; Turányi E; Meggyesházi N; Molnár IA; Fillinger J; Soltész I; Bálint K; Hanzély Z; Arató G; Szendröi M; Kulka J
    J Clin Pathol; 2015 Apr; 68(4):274-82. PubMed ID: 25595275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease.
    Cote RJ; Rosen PP; Hakes TB; Sedira M; Bazinet M; Kinne DW; Old LJ; Osborne MP
    Am J Surg Pathol; 1988 May; 12(5):333-40. PubMed ID: 3364618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.